I-124-CLR1404
DCL-13-002
Phase 2 small_molecule terminated
Quick answer
I-124-CLR1404 for Glioblastoma is a Phase 2 program (small_molecule) at Cellectar Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cellectar Biosciences
- Indication
- Glioblastoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated